Literature DB >> 16423890

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.

T Jess1, E V Loftus, W S Harmsen, A R Zinsmeister, W J Tremaine, L J Melton, P Munkholm, W J Sandborn.   

Abstract

BACKGROUND AND AIMS: We followed a population based cohort of patients with inflammatory bowel disease (IBD) from Olmsted County, Minnesota, in order to analyse long term survival and cause specific mortality.
MATERIAL AND METHODS: A total of 692 patients were followed for a median of 14 years. Standardised mortality ratios (SMRs, observed/expected deaths) were calculated for specific causes of death. Cox proportional hazards regression was used to determine if clinical variables were independently associated with mortality.
RESULTS: Fifty six of 314 Crohn's disease patients died compared with 46.0 expected (SMR 1.2 (95% confidence interval (CI) 0.9-1.6)), and 62 of 378 ulcerative colitis (UC) patients died compared with 79.2 expected (SMR 0.8 (95% CI 0.6-1.0)). Eighteen patients with Crohn's disease (32%) died from disease related complications, and 12 patients (19%) died from causes related to UC. In Crohn's disease, an increased risk of dying from non-malignant gastrointestinal causes (SMR 6.4 (95% CI 3.2-11.5)), gastrointestinal malignancies (SMR 4.7 (95% CI 1.7-10.2)), and chronic obstructive pulmonary disease (COPD) (SMR 3.5 (95% CI 1.3-7.5)) was observed. In UC, cardiovascular death was reduced (SMR 0.6 (95% CI 0.4-0.9)). Increased age at diagnosis and male sex were associated with mortality in both subtypes. In UC but not Crohn's disease, a diagnosis after 1980 was associated with decreased mortality.
CONCLUSIONS: In this population based study of IBD patients from North America, overall survival was similar to that expected in the US White population. Crohn's disease patients were at increased risk of dying from gastrointestinal disease and COPD whereas UC patients had a decreased risk of cardiovascular death.

Entities:  

Mesh:

Year:  2006        PMID: 16423890      PMCID: PMC1860022          DOI: 10.1136/gut.2005.079350

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study.

Authors:  M Orholm; V Binder; T I Sørensen; L P Rasmussen; K O Kyvik
Journal:  Scand J Gastroenterol       Date:  2000-10       Impact factor: 2.423

2.  Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England.

Authors:  F Farrokhyar; E T Swarbrick; R H Grace; M D Hellier; A E Gent; E J Irvine
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study.

Authors:  A Viscido; V Bagnardi; G C Sturniolo; V Annese; G Frieri; A D'Arienzo; C Papi; G Riegler; G Corrao; R Caprilli
Journal:  Dig Liver Dis       Date:  2001-11       Impact factor: 4.088

5.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.

Authors:  Tine Jess; Edward V Loftus; Fernando S Velayos; W Scott Harmsen; Alan R Zinsmeister; Thomas C Smyrk; Cathy D Schleck; William J Tremaine; L Joseph Melton; Pia Munkholm; William J Sandborn
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

Authors:  Karen Vanessa Winther; Tine Jess; Ebbe Langholz; Pia Munkholm; Vibeke Binder
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County.

Authors:  T Ljung; P Karlén; D Schmidt; P M Hellström; A Lapidus; I Janczewska; U Sjöqvist; R Löfberg
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

9.  Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

Authors:  Tine Jess; Karen Vanessa Winther; Pia Munkholm; Ebbe Langholz; Vibeke Binder
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

10.  Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.

Authors:  G Masala; S Bagnoli; M Ceroti; C Saieva; G Trallori; I Zanna; G D'Albasio; D Palli
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

View more
  58 in total

Review 1.  Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease--review of the literature.

Authors:  Andreas G Wibmer; Anton J Kroesen; Jörn Gröne; Heinz-Johannes Buhr; Joerg-Peter Ritz
Journal:  Int J Colorectal Dis       Date:  2010-07-14       Impact factor: 2.571

2.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

3.  Timing of surgery for inflammatory bowel disease.

Authors:  J D Sanderson; G C Parkes
Journal:  BMJ       Date:  2007-10-30

4.  Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.

Authors:  Anders Ekbom; Lena Brandt; Fredrik Granath; Claes-Göran Löfdahl; Arne Egesten
Journal:  Lung       Date:  2008-03-11       Impact factor: 2.584

5.  Presentation and disease course in early- compared to later-onset pediatric Crohn's disease.

Authors:  Neera Gupta; Alan G Bostrom; Barbara S Kirschner; Stanley A Cohen; Oren Abramson; George D Ferry; Benjamin D Gold; Harland S Winter; Robert N Baldassano; Terry Smith; Melvin B Heyman
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

Review 6.  Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

Authors:  Irene Modesto; Giovanni Perricone; Ambrogio Orlando; Mario Cottone
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

7.  Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.

Authors:  Angelica Nocerino; Alexandra Feathers; Elena Ivanina; Laura Durbin; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

8.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

Review 9.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

Review 10.  Hematopoietic cell transplantation for Crohn's disease; is it time?

Authors:  Y Leung; M Geddes; J Storek; R Panaccione; P L Beck
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.